Global Database of Emerging Companies

A powerful research and due diligence tool for investors, entrepreneurs, and business development executives

The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.

Searched: Management-Consulting             1 - 30 of 52 results       Next >

InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 2 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 2 of 5.


InHealth 2010 Health Technology Summit: Controlling Technology: Are Insurers Ready? (Part 1 of 5)

Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 1 of 5.


Management Interview: Epion Health

Management Interview: Epion Health


Management Interview: Aptiv Solutions

Management Interview: Aptiv Solutions


Inside Endeavour Vision: Interviews with the Management

Inside Endeavour Vision: Interviews with the Management


Management Interview: RAPID Pharmaceuticals

RAPID Pharmaceuticals focuses on developing pharmaceutical compounds modulating the activity of cell surface receptors. Their technology allows the synthesis of short receptor active peptides derived from larger human or viral proteins, which they modify and stabilize into potent bioactive therapeutic compounds. These therapeutic compounds of endogenous peptide hormones or proteins may then be used as bodywide mediators that regulate communication within and among the nervous, immune and glandular systems.


Management Interview: CeQur

CeQur is an insulin delivery device company, developing and commercializing a small, discrete, and uniquely simple insulin delivery device for people with type 2 diabetes. The Company was established in January 2008 as a spin-out from Danfoss A/S, a large, global, Danish industrial products group that had developed the core technology, product concept and early prototypes. CeQur is a Swiss-registered private company with operations in Denmark and Marlborough, MA, USA.


Management Interview: Neil Warma, CEO of Opexa Therapeutics

Management Interview: Neil Warma, CEO of Opexa Therapeutics


Management Interview: Evian Gordon of Brain Resource

Management Interview: Evian Gordon of Brain Resource


Management Interview: Mitchell Seyedin, CEO of ISTO Technologies

Management Interview: Mitchell Seyedin, CEO of ISTO Technologies


Management Interview: Aftab Jamil, of BDO USA

Management Interview: Aftab Jamil, of BDO USA


Management Interview: Micro Interventional Devices

Management Interview: Micro Interventional Devices


Management Interview: Greater Zurich Area AG

Management Interview: Greater Zurich Area AG


Management Video: Dr. Phillip Chan, CEO of CytoSorbents

OneMedTV interviews Dr. Phillip Chan, CEO of CytoSorbents at the OneMedForum San Francisco 2012.


Management Interview: Gregory J. Kuehn, of Metabiomics

Management Interview: Gregory J. Kuehn, of Metabiomics


Management Interview: Pat Donnelly, CEO of Aptiv Solutions

Management Interview: Pat Donnelly, CEO of Aptiv Solutions


OMFSF11 - EpiCept Presentation

EpiCept presents at OneMedForum San Francisco 2011


Management Video: Gemma García Zato of 2B Blackbio

Gemma García Zato, Co-Founder and Deputy General Manager of 2B Blackbio, is interviewed at the 2012 OneMedForum San Francisco.


PDS Biotechnology - Interview with President and CEO Frank Bedu-Addo

Frank K. Bedu-Addo, Ph.D., President and CEO of Pds Biotechnology, discusses their therapeutic vaccine technology, how it works, and how PDS plans to apply that technology moving forward.


Icagen Presentation at the 2010 OneMedForum

P. Kay Wagoner, President, CEO, and Director of Icagen, gives a presentation on her company at the 2010 OneMedForum in San Francisco.


OMFNY2011 Presentation: WaferGen Biosystems

WaferGen Biosystems, Inc., provides genomics analysis solutions from research to clinic for the life science and pharmaceutical industries. Its high-throughput, nano-scale genomics solutions are designed to revolutionize disease research, improve drug development efficiency, enable personalized medicine and impact health care economics. Its experienced management team drives a compelling business model that brings revenue from sales of its high margin instruments and recurring-revenue of consumables (chips).


P&M Corporate Finance - Interview with Director Bryan Hughes

Bryan W. Hughes, Director at P&m Corporate Finance, discusses his company, with a focus on their advisory services for middle market companies.


Searched: Management-Consulting             1 - 30 of 52 results       Next >